Improved reporting of delivered dose intensity is needed in clinical trials of chemotherapy in non-Hodgkin's lymphoma (NHL).
Publication
, Conference
Dale, DC; Crawford, J; McCarter, G; Lyman, GH
Published in: BLOOD
2001
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
2001
Volume
98
Issue
11
Start / End Page
240B / 240B
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Dale, D. C., Crawford, J., McCarter, G., & Lyman, G. H. (2001). Improved reporting of delivered dose intensity is needed in clinical trials of chemotherapy in non-Hodgkin's lymphoma (NHL). In BLOOD (Vol. 98, pp. 240B-240B).
Dale, D. C., J. Crawford, G. McCarter, and G. H. Lyman. “Improved reporting of delivered dose intensity is needed in clinical trials of chemotherapy in non-Hodgkin's lymphoma (NHL).” In BLOOD, 98:240B-240B, 2001.
Dale DC, Crawford J, McCarter G, Lyman GH. Improved reporting of delivered dose intensity is needed in clinical trials of chemotherapy in non-Hodgkin's lymphoma (NHL). In: BLOOD. 2001. p. 240B-240B.
Dale, D. C., et al. “Improved reporting of delivered dose intensity is needed in clinical trials of chemotherapy in non-Hodgkin's lymphoma (NHL).” BLOOD, vol. 98, no. 11, 2001, pp. 240B-240B.
Dale DC, Crawford J, McCarter G, Lyman GH. Improved reporting of delivered dose intensity is needed in clinical trials of chemotherapy in non-Hodgkin's lymphoma (NHL). BLOOD. 2001. p. 240B-240B.
Published In
BLOOD
ISSN
0006-4971
Publication Date
2001
Volume
98
Issue
11
Start / End Page
240B / 240B
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology